{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-012377","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.137601+00:00","generated_at":"2026-06-17T01:54:43.855877+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioRestorative enters ATM equity facility with JonesTrading for up to $3.7M","bullets":["Capital On Demand Sales Agreement signed April 14, 2023 with JonesTrading Institutional Services LLC.","Company may sell up to $3.7 million of common stock from time to time in at-the-market offerings.","Agent commission is 3.0% of gross sale proceeds; company not obligated to sell any shares.","Sales will be under existing effective S-3 registration statement (No. 333-269631) filed Feb 2023.","Agreement can be terminated by either party at any time upon notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-012377","json":"https://secwatch.observer/filing/0001493152-23-012377.json","markdown":"https://secwatch.observer/filing/0001493152-23-012377.md","text":"https://secwatch.observer/filing/0001493152-23-012377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000149315223012377/0001493152-23-012377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000149315223012377/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:54:43.855877+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c2386cc2228c50bc0891f073c87a83aa0ff52802","claim":"BioRestorative Therapies, Inc. entered into Sales Agreement with JonesTrading Institutional Services LLC valued at up to $3.7 million (effective 2023-04-14).","evidence_excerpt":"BioRestorative Therapies, Inc. (the “Company”) entered into a Capital On DemandTM Sales Agreement (the “Sales Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $3.7 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000149315223012377/0001493152-23-012377-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"JonesTrading Institutional Services LLC"},{"label":"Value","value":"up to $3.7 million"},{"label":"Effective","value":"2023-04-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}